全文获取类型
收费全文 | 1095871篇 |
免费 | 74627篇 |
国内免费 | 1589篇 |
专业分类
耳鼻咽喉 | 15405篇 |
儿科学 | 34938篇 |
妇产科学 | 29107篇 |
基础医学 | 156627篇 |
口腔科学 | 30156篇 |
临床医学 | 96797篇 |
内科学 | 207835篇 |
皮肤病学 | 24887篇 |
神经病学 | 83106篇 |
特种医学 | 44354篇 |
外国民族医学 | 201篇 |
外科学 | 166645篇 |
综合类 | 21912篇 |
现状与发展 | 1篇 |
一般理论 | 273篇 |
预防医学 | 75576篇 |
眼科学 | 25119篇 |
药学 | 88150篇 |
8篇 | |
中国医学 | 3047篇 |
肿瘤学 | 67943篇 |
出版年
2021年 | 8209篇 |
2019年 | 8360篇 |
2018年 | 11930篇 |
2017年 | 9428篇 |
2016年 | 10710篇 |
2015年 | 12182篇 |
2014年 | 16413篇 |
2013年 | 23476篇 |
2012年 | 32487篇 |
2011年 | 34138篇 |
2010年 | 20112篇 |
2009年 | 18867篇 |
2008年 | 31370篇 |
2007年 | 33411篇 |
2006年 | 33944篇 |
2005年 | 32219篇 |
2004年 | 30763篇 |
2003年 | 29452篇 |
2002年 | 28318篇 |
2001年 | 60423篇 |
2000年 | 61889篇 |
1999年 | 51271篇 |
1998年 | 12600篇 |
1997年 | 11149篇 |
1996年 | 11139篇 |
1995年 | 10427篇 |
1994年 | 9420篇 |
1993年 | 8939篇 |
1992年 | 37928篇 |
1991年 | 36380篇 |
1990年 | 35852篇 |
1989年 | 34380篇 |
1988年 | 30950篇 |
1987年 | 30048篇 |
1986年 | 28275篇 |
1985年 | 26488篇 |
1984年 | 19238篇 |
1983年 | 16151篇 |
1982年 | 8863篇 |
1979年 | 17067篇 |
1978年 | 11433篇 |
1977年 | 10258篇 |
1976年 | 8863篇 |
1975年 | 10098篇 |
1974年 | 11669篇 |
1973年 | 11290篇 |
1972年 | 10770篇 |
1971年 | 10105篇 |
1970年 | 9269篇 |
1969年 | 8949篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Hassen Lena M. Albarrak Rana A. Albahlal Reem A. Alsaqabi Dimah K. Hassen Ikhlass M. Daghestani Maha H. Alqurtas Eman M. Alkhalaf Abdulaziz T. Bedaiwi Mohammed K. Omair Mohammed A. Almaghlouth Ibrahim A. 《Quality of life research》2022,31(11):3229-3239
Quality of Life Research - The COVID-19 pandemic might add to the stressors experienced by people living with rheumatic diseases. This study aimed to examine rheumatic patients’ functional... 相似文献
3.
Molnár B. Aroca S. Dobos A. Orbán K. Szabó J. Windisch P. Stähli A. Sculean A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with... 相似文献
4.
5.
6.
7.
Comprehensive evidence regarding the treatment of non-anaemic iron deficiency in patients undergoing valvular heart surgery is lacking. This study aimed to investigate the association between non-anaemic iron deficiency and postoperative outcomes in these patients. We retrospectively analysed 321 patients of which 180 (56%) had iron deficiency (defined as serum ferritin < 100 ng.ml-1 or < 300 ng.ml-1 with transferrin saturation < 20%). While the iron-deficient group had lower pre-operative haemoglobin levels than the non-iron deficient group (median (IQR [range]) 134 (127–141 [120–172]) g.l-1, 143 (133–150 [120–179]) g.l-1, p = 0.001), there was no between-group difference in allogeneic red blood cell transfusion. Median (IQR [range]) days alive and out of hospital at postoperative day 90 was 1 day shorter in the iron-deficient group (80 (77–82 [9–85]) days vs. 81 (79–83 [0–85]) days, p = 0.026). In multivariable analysis, only cardiopulmonary bypass duration (p = 0.032) and intra-operative allogeneic red blood cell transfusion (p = 0.011) were significantly associated with reduced days alive and out of hospital at postoperative day 90. Iron deficiency did not exert any adverse influence on secondary outcomes except length of hospital stay. Our findings indicate that non-anaemic iron deficiency alone is not associated with adverse effects in patients undergoing valvular heart surgery when it does not translate into an increased risk of allogeneic transfusion. 相似文献
8.
9.
Malunguja Gisandu K. Devi Ashalata 《Proceedings of the National Academy of Sciences, India. Section B.》2022,92(1):105-120
Proceedings of the National Academy of Sciences, India Section B: Biological Sciences - Heavy metal concentrations in surface soils of Reserved Forests (RFs) have a significant impact on... 相似文献
10.
Purnima Gogoi Geetika Kaur Nikhlesh K Singh 《World journal of gastroenterology : WJG》2022,28(46):6497-6511
Colorectal cancer (CRC) is the third most diagnosed cancer and the second leading cause of cancer-related mortality in the United States. Across the globe, people in the age group older than 50 are at a higher risk of CRC. Genetic and environmental risk factors play a significant role in the development of CRC. If detected early, CRC is preventable and treatable. Currently, available screening methods and therapies for CRC treatment reduce the incidence rate among the population, but the micrometastasis of cancer may lead to recurrence. Therefore, the challenge is to develop an alternative therapy to overcome this complication. Nanotechnology plays a vital role in cancer treatment and offers targeted chemotherapies directly and selectively to cancer cells, with enhanced therapeutic efficacy. Additionally, nanotechnology elevates the chances of patient survival in comparison to traditional chemotherapies. The potential of nanoparticles includes that they may be used simultaneously for diagnosis and treatment. These exciting properties of nanoparticles have enticed researchers worldwide to unveil their use in early CRC detection and as effective treatment. This review discusses contemporary methods of CRC screening and therapies for CRC treatment, while the primary focus is on the theranostic approach of nanotechnology in CRC treatment and its prospects. In addition, this review aims to provide knowledge on the advancement of nanotechnology in CRC and as a starting point for researchers to think about new therapeutic approaches using nanotechnology. 相似文献